The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
stem cell replication rates do vary between different organs and this can be correlated to a higher incidence of cancer for that particular organ for example in humans colon cancer is much more common than cancer of the dun dadum the first part of the small intestine stem cells in the colon divide divide 10 the 12 times whereas stem cells in the duodenum divide 10 to the 10 times so stem cells are dividing much more rapidly over a lifetime in the colon versus the duodenum
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the study looked at stem cell divisions in different organs over a lifetime and plotted it against a lifetime risk of cancer for 31 different types of cancer
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.